LivaNova PLC (LIVN) - Product Pipeline Analysis, 2018 Update

Published by Global Data on 27th December 2018 | Ref: 1127959 | This Report Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Enterprise License
$750 | Single User
$1500 | Site License
$2250 | Enterprise License



LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for auto transfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, England, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company LivaNova PLC

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

LivaNova PLC Company Overview 6

LivaNova PLC Company Snapshot 6

LivaNova PLC Pipeline Products and Ongoing Clinical Trials Overview 6

LivaNova PLC – Pipeline Analysis Overview 9

LivaNova PLC - Key Facts 9

LivaNova PLC - Major Products and Services 10

LivaNova PLC Pipeline Products by Development Stage 11

LivaNova PLC Ongoing Clinical Trials by Trial Status 14

LivaNova PLC Pipeline Products Overview 16

Aspire NP 16

Aspire NP Product Overview 16

Caisson TMVR System 17

Caisson TMVR System Product Overview 17

Caisson TMVR System Clinical Trial 18

Centro Generator 19

Centro Generator Product Overview 19

CentroSR Generator 20

CentroSR Generator Product Overview 20

Equilia 21

Equilia Product Overview 21

Griffin - Pulse Generator 22

Griffin - Pulse Generator Product Overview 22

Intense Neuromodulation System - Heart Failure 23

Intense Neuromodulation System - Heart Failure Product Overview 23


LBATS Product Overview 24

Microburst VNS Stimulator 25

Microburst VNS Stimulator Product Overview 25

Microburst VNS Stimulator Clinical Trial 26

Nerve Wrap 27

Nerve Wrap Product Overview 27

New Oxy Apex HP Oxygenator 28

New Oxy Apex HP Oxygenator Product Overview 28

Next Generation ECMO System 29

Next Generation ECMO System Product Overview 29

Next Generation Wand - VNS Therapy 30

Next Generation Wand - VNS Therapy Product Overview 30


NINO Product Overview 31

Pediatric pVAD 32

Pediatric pVAD Product Overview 32

Perceval S – Extended Indications 33

Perceval S – Extended Indications Product Overview 33

Perceval S – Extended Indications Clinical Trial 34

Perceval Sutureless Heart Valve 35

Perceval Sutureless Heart Valve Product Overview 35

Perceval Sutureless Heart Valve Clinical Trial 36

Percutaneous Mitral Valve Repair Device 38

Percutaneous Mitral Valve Repair Device Product Overview 38

Percutaneous Mitral Valve Replacement Device 39

Percutaneous Mitral Valve Replacement Device Product Overview 39

PhoenixRF SR 40

PhoenixRF SR Product Overview 40

ProGuardian System 41

ProGuardian System Product Overview 41

Remote Monitoring System V2 42

Remote Monitoring System V2 Product Overview 42

Spiderflash AFIB 43

Spiderflash AFIB Product Overview 43

VITARIA System - Chronic Heart Failure 44

VITARIA System - Chronic Heart Failure Product Overview 44

VITARIA System - Chronic Heart Failure Clinical Trial 45

LivaNova PLC - Key Competitors 46

LivaNova PLC - Key Employees 47

LivaNova PLC - Locations And Subsidiaries 48

Head Office 48

Other Locations & Subsidiaries 48

Recent Developments 49

LivaNova PLC , Recent Developments 49

Jun 14, 2018: LivaNova Receives FDA Clearance and Completes First Implant For Its MEMO 4D Semi-rigid Mitral Annuloplasty Ring 49

Jun 14, 2018: LivaNova Receives FDA Clearance and Completes First Implant For Its MEMO 4D Semi-rigid Mitral Annuloplasty Ring 49

Jun 13, 2018: LivaNova Welcomes William Kozy to Board of Directors 50

May 30, 2018: LivaNova Comments on the U.S. Centers for Medicare & Medicaid Services’ Reconsideration of its National Coverage Determination for VNS Therapy for Treatment-Resistant Depression 50

Apr 26, 2018: LivaNova Announces One-Millionth Inspire Adult Oxygenator Patient 50

Apr 17, 2018: LivaNova Receives CE Mark for VNS Therapy SenTiva Generator and Next-Generation Programming System for Treatment of Epilepsy 51

Mar 29, 2018: LivaNova Bicarbon Aortic Valves Receive CE Mark for Expanded Use Labeling with Lower-Dose Blood Thinners in Low-Risk Patients 51

Mar 28, 2018: LivaNova Commences Clinical Study to Evaluate Treatment Outcomes for Novel Microburst VNS Therapy System 52

Mar 22, 2018: LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China 52

Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results 53

Appendix 55

Methodology 55

About GlobalData 58

Contact Us 58

Disclaimer 58

Additional Details


Global Data

Publisher Information


1127959 | GDME2467990PD

Number of Pages


Report Format


This report is published by Global Data

Download Free Report Summary PDF

LivaNova PLC (LIVN) - Product Pipeline Analysis, 2018 Update [Updated: 27-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.